NASDAQ: YHGJ

YUNHONG GREEN CTI LTD.

CIK 0001042187 · SIC 3060 · Fabricated Rubber Products, NEC

Micro Revenue $20M Assets $19M as of Sep 20, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.

10-Q Filed Aug 7, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

10-Q Filed May 13, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

Partner

Trade YHGJ commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Apr 27, 2026 · Period ending Apr 22, 2026

Summary not yet generated.

8-K Filed Mar 31, 2026 · Period ending Mar 27, 2026

Summary not yet generated.

10-K Filed Mar 23, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

8-K Filed Feb 18, 2026 · Period ending Feb 17, 2026

Summary not yet generated.

10-K Filed Apr 15, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-Q/A Filed Jun 1, 2020 · Period ending Sep 30, 2019

Summary not yet generated.

S-1 Filed Sep 19, 2018

Summary not yet generated.

424B3 Filed Oct 20, 2016

Summary not yet generated.

10-K/A Filed Dec 4, 2015 · Period ending Dec 31, 2014

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 7, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Income (Loss) (Unaudited)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Net sales 3,900,000 5,457,000 10,054,000 10,259,000
Cost of sales 3,362,000 4,479,000 8,502,000 8,415,000
Gross profit 538,000 978,000 1,552,000 1,844,000
Operating expenses:
General and administrative 675,000 754,000 1,598,000 1,593,000
Selling 34,000 37,000 71,000 72,000
Advertising and marketing 149,000 168,000 302,000 338,000
Total operating expenses 858,000 959,000 1,971,000 2,003,000
Income (loss) from operations (320,000) 19,000 (419,000) (159,000)
Other (expense) income:
Interest expense (225,000) (227,000) (467,000) (465,000)
Other income/(expense) 2,000 23,000 2,000 23,000
Total other expense, net (223,000) (204,000) (465,000) (442,000)
Net loss (543,000) (185,000) (884,000) (601,000)
Deemed dividends on preferred stock (43,000) (43,000) (86,000) (86,000)
Net loss attributable to common shareholders (586,000) (228,000) (970,000) (687,000)
Basic income (loss) per common share (0.22) (0.09) (0.37) (0.26)
Diluted income (loss) per common share (0.22) (0.09) (0.37) (0.26)
Weighted average number of shares and equivalent shares of common stock outstanding:
Basic 2,608,638 2,608,082 2,604,856 2,608,082
Diluted 2,608,638 2,608,082 2,604,856 2,608,082

Condensed Consolidated Balance Sheets (Unaudited)

Description June 30, 2026 December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents 320,000 97,000
Accounts receivable, net 3,295,000 5,955,000
Inventories 7,827,000 8,738,000
Prepaid expenses 351,000 283,000
Total current assets 11,793,000 15,073,000
Property, plant and equipment:
Machinery and equipment 21,993,000 21,993,000
Office furniture and equipment 2,122,000 2,122,000
Intellectual property 783,000 783,000
Leasehold improvements 39,000 39,000
Fixtures and equipment 518,000 518,000
Projects under construction 170,000 140,000
25,625,000 25,595,000
Less: accumulated depreciation and amortization (21,885,000) (21,599,000)
Total property, plant and equipment, net 3,740,000 3,996,000
Other assets:
Operating lease right-of-use 3,087,000 3,393,000
Total other assets 3,087,000 3,393,000
TOTAL ASSETS 18,620,000 22,462,000
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Trade payables 1,482,000 1,677,000
Line of credit 4,591,000 6,822,000
Notes payable current portion 443,000 146,000
Notes payable related party 344,000 344,000
Operating lease liabilities current portion 659,000 596,000
Advance investor deposits 225,000 150,000
Accrued liabilities 627,000 950,000
Total current liabilities 8,371,000 10,685,000
Long-term liabilities:
Notes payable net of current portion - 348,000
Operating lease liabilities noncurrent 2,526,000 2,873,000
Total long-term liabilities 2,526,000 3,221,000
TOTAL LIABILITIES 10,897,000 13,906,000
SHAREHOLDERS’ EQUITY
Series E Preferred Stock no par value, 130,000 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025 (liquidation preference of $1,300,000) 1,032,000 976,000
Series F Preferred Stock no par value, 70,000 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025 (liquidation preference of $700,000) 555,000 525,000
Common stock no par value, 2,000,000,000 shares authorized, 2,613,670 and 2,601,788 shares issued and 2,609,244 and 2,597,362 shares outstanding at June 30, 2026 and December 31, 2025, respectively 27,891,000 27,891,000
Additional paid-in-capital 7,676,000 7,711,000
Accumulated deficit (29,270,000) (28,386,000)
Less: Treasury stock, 4,426 shares, at cost (161,000) (161,000)
TOTAL SHAREHOLDERS’ EQUITY 7,723,000 8,556,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 18,620,000 22,462,000

Condensed Consolidated Statements of Cash Flows (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net loss (884,000) (601,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization 286,000 322,000
Equity compensation expense 51,000 17,000
Change in assets and liabilities:
Accounts receivable 2,660,000 1,608,000
Inventories 911,000 313,000
Prepaid expenses and other assets (68,000) 169,000
Trade payables (195,000) (104,000)
Operating leases 22,000 40,000
Advance investor deposit 75,000 -
Accrued liabilities (323,000) (50,000)
Net cash (used in) provided by operating activities 2,535,000 1,714,000
Cash flows from investing activities:
Purchases of property, plant and equipment (30,000) (42,000)
Net cash (used in) provided by investing activities (30,000) (42,000)
Cash flows from financing activities:
Repayment of note payable (51,000) (42,000)
Net repayments on revolving line of credit (2,231,000) (1,832,000)
Net cash provided by (used in) financing activities (2,282,000) (1,874,000)
Net increase (decrease) in cash and cash equivalents 223,000 (202,000)
Cash and cash equivalents at beginning of period 97,000 220,000
Cash and cash equivalents at end of period 320,000 18,000
Supplemental disclosure of cash flow information and noncash investing and financing activities:
Cash payments for interest 467,000 465,000
Accretion of dividends on preferred stock 86,000 86,000
Conversion of advance received from investors into common stock - 1,050,000
Common stock issued in exchange for rent due to Icy Mellon - 182,000

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗